Chemical Name: (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one
Synonym: Clarithromycin 9-Oxime ; 6-O-Methylerythromycin A (E)-9-oxime
Smiles: C[C@@](OC)(C[C@H](/C([C@@H]1C)=N\O)C)[C@@H]([C@H]([C@]([C@H](C(O[C@H](CC)[C@@](C)(O)[C@@H]1O)=O)C)([H])O[C@@](O[C@@H](C)[C@@H]2O)([H])C[C@@]2(C)OC)C)O[C@@](O[C@H](C)C[C@@H]3N(C)C)([H])[C@@H]3O
Inchi: InChI=1S/C37H67NO13/c1-18-16-36(9,46-14)32(51-34-28(40)25(38(11)12)15-19(2)47-34)21(4)29(50-26-17-35(8,45-13)31(42)23(6)48-26)22(5)33(43)49-24(7)37(10,44)30(41)20(3)27(18)39/h18-26,28-32,34,40-42,44H,15-17H2,1-14H3/t18-,19-,20?,21+,22-,23+,24-,25+,26+,28-,29?,30-,31+,32-,34+,35-,36-,37-/m1/s1
Stability indicating HPLC-ECD method for the analysis of clarithromycin in pharmaceutical dosage forms: method scaling versus re-validation
By Makoni, Pedzisai A.; Chikukwa, Mellisa T. R.; Khamanga, Sandile M. M.; Walker, Roderick B.
From Scientia Pharmaceutica (2019), 87(4), 31
Stability indicating Rp-Hplc method development and validation for the simultaneous estimation of gemcitabine and clarithromycin in bulk and pharmaceutical dosage form
By Kumar, Y. Anil; Sirisha, Y.; Harini, A. L.; Prathyusha, A.
From World Journal of Pharmaceutical Research (2018), 7(8Spec.Iss.), 1-8
Selecting optimal columns for clarithromycin impurity analysis according to the quantitative relationship of hydrophobic subtraction model
By Zhang Xia; Hu Changqin
From Journal of pharmaceutical and biomedical analysis (2017), 136, 162-169